BICALUTAMIDE Side Effects

7018177-0 | Blister, Erythema, Toxic Skin Eruption
on Sep 20, 2010 Male patient from PORTUGAL , weighting 176.4 lb, was diagnosed with prostate cancer (What is prostate cancer?), pain (What is pain?) and was treated with Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: blister, erythema, toxic skin eruption. Bicalutamide dosage: . During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), LYSINE (View Lysine Review and Lysine Label ), DIPYRONE TAB (View Dipyrone Tab Review and Dipyrone Tab Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6967530-X | Extradural Haematoma, Subdural Haematoma
Patient was taking Bicalutamide (View Usage). Patient had the following side effects: extradural haematoma, subdural haematoma on Aug 25, 2010 from DENMARK Additional patient health information: Male patient , 75 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Bicalutamide dosage: . During the same period patient was treated with HJERTEMAGNL (ACETYLSALICYLIC ACID, MAGNESIUM OXIDE) (View Hjertemagnl (acetylsalicylic Acid, Magnesium Oxide) Review and Hjertemagnl (acetylsalicylic Acid, Magnesium Oxide) Label ), SOTALOL (View Sotalol Review and Sotalol Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ). Patient was hospitalized and became disabled.

6967156-8 | Extradural Haematoma, Platelet Function Test Abnormal, Subdural Haematoma
Adverse event was reported on Aug 25, 2010 by a Male patient taking Bicalutamide (View Usage) (Dosage: 50 Mg, Qd, Oral) was diagnosed with prostate cancer metastatic and. Location: DENMARK , 67 years of age, After Bicalutamide was administered, patient had the following side effects: extradural haematoma, platelet function test abnormal, subdural haematoma. During the same period patient was treated with ZOLADEX (View Zoladex Review and Zoladex Label ), IRON (IRON) (View Iron (iron) Review and Iron (iron) Label ), UNIKALK BASIC (CALCIUM) (View Unikalk Basic (calcium) Review and Unikalk Basic (calcium) Label ). Patient was hospitalized and became disabled.

6963937-5 | Myalgia
on Aug 23, 2010 Male patient from DENMARK , 76 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: myalgia. Bicalutamide dosage: 150 Mg;qd;po. During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ).


6963890-4 | Extradural Haematoma, Platelet Function Test Abnormal, Subdural Haematoma, Thrombocytopenia, Treatment Failure
on Aug 19, 2010 Male patient from DENMARK , 67 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). Patient had the following side effects: extradural haematoma, platelet function test abnormal, subdural haematoma, thrombocytopenia, treatment failure. Bicalutamide dosage: 50 Mg;qd;po. During the same period patient was treated with ZOLADEX (View Zoladex Review and Zoladex Label ), UNIKALK (View Unikalk Review and Unikalk Label ), JERN (View Jern Review and Jern Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized and became disabled.

6959540-3 | Extradural Haematoma, Subdural Haematoma
Patient was taking Bicalutamide (View Usage). After Bicalutamide was administered, patient had the following side effects: extradural haematoma, subdural haematoma on Aug 19, 2010 from DENMARK Additional patient health information: Male patient , 75 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Bicalutamide dosage: . During the same period patient was treated with HJERTEMAGNYL (View Hjertemagnyl Review and Hjertemagnyl Label ), SOTALOL (View Sotalol Review and Sotalol Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized and became disabled.

6942981-8 | Rectal Haemorrhage
Adverse event was reported on Aug 24, 2010 by a Male patient taking Bicalutamide (View Usage) (Dosage: 50mg 1 Daily) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , weighting 200.0 lb, Patient experienced the following unwanted or unexpected effects: rectal haemorrhage. Patient was hospitalized.

6914832-9 | Endotracheal Intubation, Hypokalaemia, Loss Of Consciousness, Resuscitation, Speech Disorder, Torsade De Pointes, Ventricular Tachycardia
on Jul 30, 2010 Male patient from JAPAN , 82 years of age, weighting 165.3 lb, was diagnosed with prostate cancer (What is prostate cancer?), arrhythmia (What is arrhythmia?), asthma (What is asthma?), obesity (What is obesity?), benign prostatic hyperplasia, pneumonia bacterial, hypertension, angina pectoris and was treated with Bicalutamide (View Usage). Patient had the following side effects: endotracheal intubation, hypokalaemia, loss of consciousness, resuscitation, speech disorder, torsade de pointes, ventricular tachycardia. Bicalutamide dosage: 80 Mg/day. During the same period patient was treated with DISOPYRAMIDE (300 Mg, Unk) (View Disopyramide Review and Disopyramide Label ), BAKUMONDOUTO (9 G/day Containing 0.44 G/day Of Kanzou (licorice)) (View Bakumondouto Review and Bakumondouto Label ), GLYCYRRHIZA EXTRACT (9.0 G/day Of Bofutusyosan (tsumura + Co.) Containing 0.34 G/day Of Kanzou (licorice)) (View Glycyrrhiza Extract Review and Glycyrrhiza Extract Label ), SILODOSIN (8 Mg, Unk) (View Silodosin Review and Silodosin Label ), GARENOXACIN (400 Mg, Bid) (View Garenoxacin Review and Garenoxacin Label ), IMIDAPRIL HYDROCHLORIDE (5 Mg/day) (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), AMLODIPINE BESYLATE (5 Mg/day) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ISOSORBIDE MONONITRATE (40 Mg/day) (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ).

6883055-4 | Prostatic Specific Antigen Increased
on Mar 01, 2010 Male patient from UNITED STATES , 51 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). After Bicalutamide was administered, patient had the following side effects: prostatic specific antigen increased. Bicalutamide dosage: . During the same period patient was treated with ZOLADEX (View Zoladex Review and Zoladex Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ), PERCOCET (View Percocet Review and Percocet Label ).

6836742-8 | Dyspnoea, Exercise Tolerance Decreased, Schizophrenia, Somnolence
Patient was taking Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, exercise tolerance decreased, schizophrenia, somnolence on Jun 29, 2010 from GERMANY Additional patient health information: Male patient , 60 years of age, weighting 187.4 lb, was diagnosed with prostate cancer (What is prostate cancer?), supraventricular tachycardia, psychotic disorder (What is psychotic disorder?) and. Bicalutamide dosage: . During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ), RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

6826144-2 | Acute Psychosis, Dyspnoea, Exercise Tolerance Decreased, Schizophrenia, Somnolence
Adverse event was reported on Jun 29, 2010 by a Male patient taking Bicalutamide (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: GERMANY , 60 years of age, weighting 187.4 lb, Patient had the following side effects: acute psychosis, dyspnoea, exercise tolerance decreased, schizophrenia, somnolence. Patient was hospitalized.

6819989-6 | Acute Psychosis, Dyspnoea, Exercise Tolerance Decreased, Schizophrenia, Somnolence
on Jun 30, 2010 Male patient from GERMANY , 60 years of age, weighting 187.4 lb, was diagnosed with prostate cancer (What is prostate cancer?), supraventricular tachycardia, psychotic disorder (What is psychotic disorder?) and was treated with Bicalutamide (View Usage). After Bicalutamide was administered, patient had the following side effects: acute psychosis, dyspnoea, exercise tolerance decreased, schizophrenia, somnolence. Bicalutamide dosage: . During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ), RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

6791237-5 | Arthralgia, Gait Disturbance, Muscle Rigidity
on Jun 10, 2010 Male patient from NETHERLANDS , 69 years of age, weighting 154.3 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, gait disturbance, muscle rigidity. Bicalutamide dosage: .

6762464-8 | Toxic Skin Eruption
Patient was taking Bicalutamide (View Usage). Patient had the following side effects: toxic skin eruption on May 28, 2010 from PORTUGAL Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with prostate cancer (What is prostate cancer?) and. Bicalutamide dosage: . During the same period patient was treated with AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ).

6729863-1 | Depressed Mood, Prostatic Specific Antigen Abnormal
Adverse event was reported on May 03, 2010 by a Male patient taking Bicalutamide (View Usage) (Dosage: 150 Mg;qd) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: DENMARK , 85 years of age, After Bicalutamide was administered, patient had the following side effects: depressed mood, prostatic specific antigen abnormal.

6697378-5 | Loss Of Consciousness, Pneumonia Bacterial, Speech Disorder, Torsade De Pointes
on Apr 21, 2010 Male patient from JAPAN , 82 years of age, weighting 165.3 lb, was diagnosed with prostate cancer (What is prostate cancer?), arrhythmia (What is arrhythmia?), pneumonia (What is pneumonia?), benign prostatic hyperplasia, hypertension, angina pectoris, hyperlipidaemia, depression (What is depression?) and was treated with Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, pneumonia bacterial, speech disorder, torsade de pointes. Bicalutamide dosage: . During the same period patient was treated with DISOPYRAMIDE (View Disopyramide Review and Disopyramide Label ), GARENOXACIN (View Garenoxacin Review and Garenoxacin Label ), SILODOSIN (View Silodosin Review and Silodosin Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), FLUTOPRAZEPAM (View Flutoprazepam Review and Flutoprazepam Label ).

6692539-3 | Blood Iron Increased, Cytomegalovirus Test Positive, Epstein-barr Virus Antigen Positive, Hepatitis Cholestatic, Hepatitis Toxic, International Normalised Ratio Decreased, Serum Ferritin Increased
on Apr 06, 2010 Male patient from DENMARK , 63 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). Patient had the following side effects: blood iron increased, cytomegalovirus test positive, epstein-barr virus antigen positive, hepatitis cholestatic, hepatitis toxic, international normalised ratio decreased, serum ferritin increased. Bicalutamide dosage: 50 Mg; Qd; Po. During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), MOXALOLE (View Moxalole Review and Moxalole Label ), MALFIN (View Malfin Review and Malfin Label ), UNIKALK PLUS (View Unikalk Plus Review and Unikalk Plus Label ), PINEX /CAN/ (View Pinex /can/ Review and Pinex /can/ Label ). Patient was hospitalized.

6690423-2 | Asthenia, Breast Enlargement, Decreased Activity, Hot Flush, Nocturia, Weight Increased, Weight Loss Poor
Patient was taking Bicalutamide (View Usage). After Bicalutamide was administered, patient had the following side effects: asthenia, breast enlargement, decreased activity, hot flush, nocturia, weight increased, weight loss poor on Nov 17, 2009 from FRANCE Additional patient health information: Male patient , weighting 185.2 lb, was diagnosed with prostate cancer (What is prostate cancer?) and. Bicalutamide dosage: . During the same period patient was treated with LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), CALCIUM PHOSPHATE (View Calcium Phosphate Review and Calcium Phosphate Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6668428-7 | Myalgia
Adverse event was reported on Mar 18, 2010 by a Male patient taking Bicalutamide (View Usage) (Dosage: 150 Mg;qd;po) was diagnosed with benign prostatic hyperplasia and. Location: UNITED KINGDOM , 76 years of age, Patient experienced the following unwanted or unexpected effects: myalgia. During the same period patient was treated with ACETYSALICYLIC ACID (View Acetysalicylic Acid Review and Acetysalicylic Acid Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ).

6603226-1 | Hepatitis Cholestatic, Hepatitis Toxic
on Feb 01, 2010 Male patient from DENMARK , 63 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). Patient had the following side effects: hepatitis cholestatic, hepatitis toxic. Bicalutamide dosage: 50 Mg;qd;po. During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), MOXALOLE (View Moxalole Review and Moxalole Label ), MALFIN (View Malfin Review and Malfin Label ), UNIKALK PULS (View Unikalk Puls Review and Unikalk Puls Label ), PINEX (View Pinex Review and Pinex Label ). Patient was hospitalized.

6520750-0 | Myocardial Infarction
on Dec 15, 2009 Male patient from GERMANY , 83 years of age, was diagnosed with prostate cancer (What is prostate cancer?), prophylaxis, hypertension, diabetes mellitus and was treated with Bicalutamide (View Usage). After Bicalutamide was administered, patient had the following side effects: myocardial infarction. Bicalutamide dosage: . During the same period patient was treated with LEUPROLIDE ACETATE (3-months-depot) (View Leuprolide Acetate Review and Leuprolide Acetate Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), PENTAERITHRITYL TETRANITRATE (View Pentaerithrityl Tetranitrate Review and Pentaerithrityl Tetranitrate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), INSULIN (View Insulin Review and Insulin Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), EPOETIN NOS (View Epoetin Nos Review and Epoetin Nos Label ). Patient was hospitalized.

6505855-2 | Thrombocytopenia
Patient was taking Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia on Nov 26, 2009 from SPAIN Additional patient health information: Male patient , 80 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Bicalutamide dosage: . During the same period patient was treated with LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6491898-4 | Blood Ph Increased, Cough, Dyspnoea, Electrocardiogram Qt Prolonged, Electrocardiogram T Wave Amplitude Decreased, Hypokalaemia, Loss Of Consciousness, Pneumonia Bacterial, Speech Disorder
Adverse event was reported on Nov 24, 2009 by a Male patient taking Bicalutamide (View Usage) (Dosage: (80 Mg Qd)) was diagnosed with obesity (What is obesity?), prostate cancer (What is prostate cancer?), arrhythmia (What is arrhythmia?), pneumonia bacterial, asthma (What is asthma?), benign prostatic hyperplasia and. Location: JAPAN , 82 years of age, weighting 165.3 lb, Patient had the following side effects: blood ph increased, cough, dyspnoea, electrocardiogram qt prolonged, electrocardiogram t wave amplitude decreased, hypokalaemia, loss of consciousness, pneumonia bacterial, speech disorder. During the same period patient was treated with DISOPYRAMIDE ((300 Mg (frequency Not Reported))) (View Disopyramide Review and Disopyramide Label ), GARENOXACIN MESYLATE ((800 Mg Daily (twice) Oral)) (View Garenoxacin Mesylate Review and Garenoxacin Mesylate Label ), LICORICE /01125801/ (KANZOU (LICORICE)) ((total Of .78 G/day (.44 G/day In 9.0 G/day Of Bakumondoto + .34g/day In 9 G/day Of Bofutusyosan))) (View Licorice /01125801/ (kanzou (licorice)) Review and Licorice /01125801/ (kanzou (licorice)) Label ), IMIDAPRIL HYDROCHLORIDE (View Imidapril Hydrochloride Review and Imidapril Hydrochloride Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ). Patient was hospitalized.

6463976-7 | Bladder Cancer Recurrent, Metastases To Lymph Nodes, Prostatic Specific Antigen Increased
on Nov 12, 2009 Male patient from JAPAN , 74 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). After Bicalutamide was administered, patient had the following side effects: bladder cancer recurrent, metastases to lymph nodes, prostatic specific antigen increased. Bicalutamide dosage: (80 Mg Qd Oral). During the same period patient was treated with LEUPRORELIN ACETATE (View Leuprorelin Acetate Review and Leuprorelin Acetate Label ). Patient was hospitalized.

6326382-1 | Metastases To Lymph Nodes, Neoplasm Recurrence, Prostatic Specific Antigen Increased
on Aug 06, 2009 Male patient from JAPAN , 74 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: metastases to lymph nodes, neoplasm recurrence, prostatic specific antigen increased. Bicalutamide dosage: 80 Mg Qd. During the same period patient was treated with GONADOTROPHINE RELEASING HORMONE ANALOGUES (View Gonadotrophine Releasing Hormone Analogues Review and Gonadotrophine Releasing Hormone Analogues Label ). Patient was hospitalized.

6186794-6 | Bronchitis, Chest Pain, Depression, Dyspnoea, Lung Infiltration, Pulmonary Fibrosis
Patient was taking Bicalutamide (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), chest pain (What is chest pain?), depression (What is depression?), dyspnoea, lung infiltration, pulmonary fibrosis (What is pulmonary fibrosis?) on May 08, 2009 from UNITED STATES Additional patient health information: Male patient , 81 years of age, weighting 123.5 lb, was diagnosed with prostate cancer (What is prostate cancer?) and. Bicalutamide dosage: 50 Mg Every Day Po. Patient was hospitalized.

6159323-0 | Haematemesis, Haemorrhagic Anaemia, Melaena, Pneumonia Aspiration
Adverse event was reported on Apr 14, 2009 by a Male patient taking Bicalutamide (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?), pneumonia (What is pneumonia?), hypokalaemia, oral candidiasis, chronic obstructive pulmonary disease, acute myocardial infarction, thrombosis prophylaxis and. Location: NORWAY , weighting 154.3 lb, After Bicalutamide was administered, patient had the following side effects: haematemesis, haemorrhagic anaemia, melaena, pneumonia aspiration. During the same period patient was treated with BENZATHINE PENICILLIN G (Unk) (View Benzathine Penicillin G Review and Benzathine Penicillin G Label ), KALEORID (View Kaleorid Review and Kaleorid Label ), MYCOSTATIN (View Mycostatin Review and Mycostatin Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), SERETIDE (Unk) (View Seretide Review and Seretide Label ), PHENOXYMETHYLPENICILLIN (Unk) (View Phenoxymethylpenicillin Review and Phenoxymethylpenicillin Label ), ALBYL E (View Albyl-e Review and Albyl-e Label ), FRAGMIN (View Fragmin Review and Fragmin Label ).

6028103-9 | Gastric Disorder, Hepatitis Toxic, Ileus Paralytic, International Normalised Ratio Increased, Liver Disorder, Vomiting
on Dec 31, 2008 Male patient from UNITED STATES , 80 years of age, weighting 165.3 lb, was diagnosed with prophylaxis, prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: gastric disorder, hepatitis toxic, ileus paralytic, international normalised ratio increased, liver disorder, vomiting. Bicalutamide dosage: 100 Mg 50 Mg Every 12 Hrs Buccal. Patient was hospitalized.

5872054-7 | Cardiomyopathy, Hepatotoxicity, Hypotension, Multi-organ Failure, Pyrexia, Renal Failure Acute, Tachycardia
on Aug 29, 2008 Male patient from UNITED STATES , 59 years of age, was diagnosed with prostate cancer metastatic and was treated with Bicalutamide (View Usage). Patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), hepatotoxicity, hypotension, multi-organ failure, pyrexia, renal failure acute, tachycardia. Bicalutamide dosage: . During the same period patient was treated with CISPLATIN (4 Cycles) (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (Given On Day 1, Patient Received 4 Cylces) (View Etoposide Review and Etoposide Label ), ACETAMINOPHEN AND OXYCODONE HCL (View Acetaminophen And Oxycodone Hcl Review and Acetaminophen And Oxycodone Hcl Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ). Patient was hospitalized.

5868861-7 | Hepatotoxicity, Hypotension, Multi-organ Failure, Tachycardia
Patient was taking Bicalutamide (View Usage). After Bicalutamide was administered, patient had the following side effects: hepatotoxicity, hypotension, multi-organ failure, tachycardia on Aug 27, 2008 from UNITED STATES Additional patient health information: Male patient , 59 years of age, was diagnosed with prostate cancer metastatic and. Bicalutamide dosage: .

5467238-6 | Toxic Skin Eruption
Adverse event was reported on Sep 14, 2007 by a Male patient taking Bicalutamide (View Usage) (Dosage: Unk) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: FRANCE , 78 years of age, Patient experienced the following unwanted or unexpected effects: toxic skin eruption. During the same period patient was treated with SOTALOL HYDROCHLORIDE (Unk) (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), ELIGARD (View Eligard Review and Eligard Label ). Patient was hospitalized.

5464465-9 | Breast Cancer Male
on Sep 04, 2007 Male patient from UNITED STATES , 81 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). Patient had the following side effects: breast cancer male. Bicalutamide dosage: . During the same period patient was treated with ELIGARD (22.5 Mg Every Three Months) (View Eligard Review and Eligard Label ).

5456897-X | Breast Cancer Male
on Sep 07, 2007 Male patient from UNITED STATES , 81 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). After Bicalutamide was administered, patient had the following side effects: breast cancer male. Bicalutamide dosage: . During the same period patient was treated with ELIGARD (22.5 Mg Every Three Months) (View Eligard Review and Eligard Label ).

5397934-0 | Cushing's Syndrome
Patient was taking Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: cushing's syndrome on Jul 19, 2007 from JAPAN Additional patient health information: Male patient , 78 years of age, . Bicalutamide dosage: . During the same period patient was treated with LEUPROLIDE ACETATE (View Leuprolide Acetate Review and Leuprolide Acetate Label ).

5370685-4 | Arthralgia, Hot Flush, Myalgia
Adverse event was reported on Jun 25, 2007 by a Male patient taking Bicalutamide (View Usage) (Dosage: Unk) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: FRANCE , 48 years of age, Patient had the following side effects: arthralgia, hot flush, myalgia. During the same period patient was treated with ELIGARD (View Eligard Review and Eligard Label ).

5315620-X | Cardiac Failure
on Apr 24, 2007 Male patient from UNITED KINGDOM , 68 years of age, weighting 185.2 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). After Bicalutamide was administered, patient had the following side effects: cardiac failure. Bicalutamide dosage: . During the same period patient was treated with TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), ZOLADEX (View Zoladex Review and Zoladex Label ). Patient was hospitalized.

5201965-0 | Abdominal Distension, Abdominal Pain Lower, Abdominal Tenderness, Acute Myocardial Infarction, Liver Disorder, Multi-organ Failure
on Jan 04, 2007 Male patient from UNITED STATES , 59 years of age, was diagnosed with neoplasm malignant and was treated with Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain lower, abdominal tenderness, acute myocardial infarction, liver disorder, multi-organ failure. Bicalutamide dosage: 50mg Po Daily. Patient was hospitalized.

5195541-6 | Activated Partial Thromboplastin Time Prolonged, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bladder Diverticulum, Calculus Bladder, Deep Vein Thrombosis, Haematuria, Haemoglobin Decreased, Hydronephrosis
Patient was taking Bicalutamide (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, bladder diverticulum, calculus bladder, deep vein thrombosis (What is deep vein thrombosis?), haematuria, haemoglobin decreased, hydronephrosis on Dec 22, 2006 from UNITED STATES Additional patient health information: Male patient , 79 years of age, weighting 134.5 lb, was diagnosed with prostate cancer (What is prostate cancer?) and. Bicalutamide dosage: 50 Mg Daily Po. Patient was hospitalized.

5143914-X | Neutropenia, Pneumonia
Adverse event was reported on Oct 30, 2006 by a Male patient taking Bicalutamide (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 80 years of age, After Bicalutamide was administered, patient had the following side effects: neutropenia, pneumonia (What is pneumonia?). During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LOSARTAN POSTASSIUM (View Losartan Postassium Review and Losartan Postassium Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized and became disabled.

5134738-8 | Renal Failure, Renal Failure Acute, Rhabdomyolysis
on Oct 19, 2006 Male patient from UNITED KINGDOM , 75 years of age, weighting 162.5 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure, renal failure acute, rhabdomyolysis. Bicalutamide dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

5116784-3 | Dermatitis Exfoliative, Rash, Toxic Skin Eruption
on Sep 19, 2006 Male patient from FRANCE , 78 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). Patient had the following side effects: dermatitis exfoliative, rash (What is rash?), toxic skin eruption. Bicalutamide dosage: Unk. During the same period patient was treated with SOTALOL HYDROCHLORIDE (Unk) (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), ELIGARD (Unk) (View Eligard Review and Eligard Label ). Patient was hospitalized.

5108317-2 | Syncope
Patient was taking Bicalutamide (View Usage). After Bicalutamide was administered, patient had the following side effects: syncope on Sep 14, 2006 from UNITED STATES Additional patient health information: Male patient , 58 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and. Bicalutamide dosage: . During the same period patient was treated with GOSERELIN 10.8 MG SQ Q3M (View Goserelin 10.8 Mg Sq Q3m Review and Goserelin 10.8 Mg Sq Q3m Label ), SEREVENT (View Serevent Review and Serevent Label ), ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE (View Albuterol Sulfate And Ipratropium Bromide Review and Albuterol Sulfate And Ipratropium Bromide Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5089018-6 | Dyspnoea, Exercise Tolerance Decreased, Left Ventricular Failure
Adverse event was reported on Jul 07, 2006 by a Male patient taking Bicalutamide (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED KINGDOM , 84 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, exercise tolerance decreased, left ventricular failure. During the same period patient was treated with CYPROTERONE ACETATE (View Cyproterone Acetate Review and Cyproterone Acetate Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

5051468-1 | Dyspnoea, Exercise Tolerance Decreased, Left Ventricular Failure
on Jul 07, 2006 Male patient from UNITED KINGDOM , 84 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). Patient had the following side effects: dyspnoea, exercise tolerance decreased, left ventricular failure. Bicalutamide dosage: . During the same period patient was treated with CYPROTERONE ACETATE (View Cyproterone Acetate Review and Cyproterone Acetate Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

4950796-5 | Abdominal Pain, Bone Disorder, Metastasis, Performance Status Decreased, Rectal Cancer Metastatic
on Mar 21, 2006 Male patient from UNITED STATES , weighting 229.3 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Bicalutamide (View Usage). After Bicalutamide was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), bone disorder, metastasis, performance status decreased, rectal cancer metastatic. Bicalutamide dosage: 50 Mg. During the same period patient was treated with ZOLADEX (10.8 Mg) (View Zoladex Review and Zoladex Label ).

4941094-4 | Gastrointestinal Haemorrhage, Thrombocytopenia
Patient was taking Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, thrombocytopenia on Mar 07, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 70 years of age, weighting 220.5 lb, was diagnosed with prostate cancer (What is prostate cancer?), hypertension, pain (What is pain?) and. Bicalutamide dosage: . During the same period patient was treated with NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), DICLOFENAC EPOLAMINE PATCH (50 Mg Tid Prn) (View Diclofenac Epolamine Patch Review and Diclofenac Epolamine Patch Label ).

4935016-X | Breast Tenderness, Gynaecomastia
Adverse event was reported on Mar 06, 2006 by a Male patient taking Bicalutamide (View Usage) (Dosage: 50 Mg Po Daily) was diagnosed with prostate cancer (What is prostate cancer?) and. Location: UNITED STATES , 89 years of age, weighting 145.1 lb, Patient had the following side effects: breast tenderness, gynaecomastia.

4896411-0 | Diabetes Mellitus, Hyperglycaemia, Insulin Resistance, Weight Increased
on Dec 12, 2005 Male patient from UNITED STATES , 66 years of age, was diagnosed with prostate cancer (What is prostate cancer?), metastases to bone, diabetes mellitus and was treated with Bicalutamide (View Usage). After Bicalutamide was administered, patient had the following side effects: diabetes mellitus, hyperglycaemia, insulin resistance, weight increased. Bicalutamide dosage: . During the same period patient was treated with LEUPROLIDE (View Leuprolide Review and Leuprolide Label ), GLUCOTROL XL (View Glucotrol Xl Review and Glucotrol Xl Label ).

4862487-X | Hyperglycaemia, Insulin Resistance
on Dec 12, 2005 Male patient from UNITED STATES , 66 years of age, was diagnosed with prostate cancer (What is prostate cancer?), metastases to bone and was treated with Bicalutamide (View Usage). Patient experienced the following unwanted or unexpected effects: hyperglycaemia, insulin resistance. Bicalutamide dosage: . During the same period patient was treated with LEUPROLIDE (View Leuprolide Review and Leuprolide Label ).

4781192-1 | Swollen Tongue
Patient was taking Bicalutamide (View Usage). Patient had the following side effects: swollen tongue on Sep 19, 2005 from UNITED KINGDOM Additional patient health information: Male patient , 75 years of age, was diagnosed with prostate cancer (What is prostate cancer?), acute coronary syndrome and. Bicalutamide dosage: . During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DICLOFENAC (View Diclofenac Review and Diclofenac Label ), CO DYDRAMOL (View Co-dydramol Review and Co-dydramol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DORZOLAMIDE (View Dorzolamide Review and Dorzolamide Label ). Patient was hospitalized.